Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2021 Jan;133(1-2):41-51.
doi: 10.1007/s00508-020-01641-w. Epub 2020 Apr 3.

Psychometric properties of the Activities Scale for Kids-performance after allogeneic hematopoietic stem cell transplantation in adolescents and children : Results of a prospective study on behalf of the German-Austrian-Swiss GVHD Consortium

Affiliations
Observational Study

Psychometric properties of the Activities Scale for Kids-performance after allogeneic hematopoietic stem cell transplantation in adolescents and children : Results of a prospective study on behalf of the German-Austrian-Swiss GVHD Consortium

Anita Lawitschka et al. Wien Klin Wochenschr. 2021 Jan.

Erratum in

Abstract

Background: The psychometric properties of an instrument, the Activity Scale for Kids-performance (ASKp), were assessed which was proposed to capture physical functioning after allogeneic hematopoietic stem cell transplantation (HSCT). Additionally, this multicenter observational prospective study investigated the influence of clinical correlates focusing on chronic graft-versus-host disease (cGVHD).

Methods: Patient-reported ASKp, clinician-reported Karnofsky/Lansky status (KPS/PSS), patient characteristics and cGVHD details were assessed of 55 patients with a median age of 12 years at baseline after day +100 post-HSCT and every 3 months during the next 18 months. The psychometric properties were evaluated and ASKp and KPS/PSS status was compared using ANOVAS and multiple regression models.

Results: The German version of the ASKp showed good psychometric properties except for ceiling effects. Discrimination ability of the ASKp was good regarding the need for devices but failed to predict cGVHD patients. Both the ASKp and the KPS/PSS were associated with patients after adoptive cell therapy being in need for devices, suffering from overlap cGVHD and from steroid side effects but not with patients' age and gender. In contrast to the KPS/PSS the ASKp only showed significant differences after merging moderate and severe cGHVD patients when comparing them to No-cGVHD (F = 4.050; p = 0.049), being outperformed by the KPS/PSS (F = 20.082; p < 0.001).

Conclusion: The ASKp showed no clear advantages compared to KPS/PSS even though economical and patients' effort was higher. Further application range may be limited through ceiling effects. Both should be taken into consideration. Therefore, the results may not support the usage of ASKp after HSCT and rather suggest KPS/PSS, both patient and clinician reported.

Keywords: AYAs; Cancer patients; GVHD; Physical functioning.

PubMed Disclaimer

Conflict of interest statement

A. Lawitschka, M. Brunmair, D. Bauer, N. Zubarovskaya, R. Felder-Puig, B. Strahm, P. Bader, G. Strauss, M. Albert, I.von Luettichau, H. Greinix, D. Wolff, and C. Peters declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
ASK©-Performance SCORE SHEET. The ASKp domains, items and response options
Fig. 2
Fig. 2
Receiver operating characteristics (ROC) curve when using ASKp scores to predict patients that need devices and patients with cGVHD. a Need of devices: ROC curve when using ASKp scores to predict patients thatneed devices; b cGVHD: ROC curve when using ASKp scores to predict patients with cGVHD
Fig. 3
Fig. 3
Standardized means of ASKp and KPS/PSS across time points. ASKp = MASK = solid line, MASK without outlier in T9 = dashed line, KPS/PSS = MKPS/PSS = dotted line

Similar articles

Cited by

References

    1. Duell T, et al. Health and functional status of long-term survivors of bone marrow transplantation. EBMT Working Party on Late Effects and EULEP Study Group on Late Effects. European Group for Blood and Marrow Transplantation. Ann Intern Med. 1997;126(3):184–192. doi: 10.7326/0003-4819-126-3-199702010-00002. - DOI - PubMed
    1. Parsons SK, Phipps S, Sung L, Baker KS, Pulsipher MA, Ness KK. NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: health-related quality of life, functional, and neurocognitive outcomes. Biol Blood Marrow Transplant. 2012;18(2):162–171. doi: 10.1016/j.bbmt.2011.12.501. - DOI - PMC - PubMed
    1. Lawitschka A, Peters C. Long-term effects of myeloablative allogeneic hematopoietic stem cell transplantation in pediatric patients with acute Lymphoblastic leukemia. Curr Oncol Rep. 2018;20(9):74. doi: 10.1007/s11912-018-0719-5. - DOI - PubMed
    1. Fraser CJ, et al. Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study. Blood. 2006;108(8):2867–2873. doi: 10.1182/blood-2006-02-003954. - DOI - PMC - PubMed
    1. Sun C-L, et al. Burden of morbidity in 10+ year survivors of hematopoietic cell transplantation: report from the bone marrow transplantation survivor study. Biol Blood Marrow Transplant. 2013;19(7):1073–1080. doi: 10.1016/j.bbmt.2013.04.002. - DOI - PMC - PubMed

Publication types

LinkOut - more resources